Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.16−0.11 (-2.58%)
Close on Nov 19, 2026Market cap $1.49BP/E –Yield –
Precigen shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Precigen's shares outstanding was 414M at Jun 30, 2026. For fiscal 2025 it was 313M, up 16.9% from the year before. Over ten years it grew 10.9% a year on average. The highest annual figure on record is 313M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 313M | +16.9% |
| FY2024 | Dec 31, 2024 | 268M | +9.5% |
| FY2023 | Dec 31, 2023 | 245M | +22.0% |
| FY2022 | Dec 31, 2022 | 200M | +1.3% |
| FY2021 | Dec 31, 2021 | 198M | +18.4% |
| FY2020 | Dec 31, 2020 | 167M | +8.4% |
| FY2019 | Dec 31, 2019 | 154M | +19.0% |
| FY2018 | Dec 31, 2018 | 130M | +7.9% |
| FY2017 | Dec 31, 2017 | 120M | +1.7% |
| FY2016 | Dec 31, 2016 | 118M | +6.2% |
| FY2015 | Dec 31, 2015 | 111M | +12.0% |
| FY2014 | Dec 31, 2014 | 99M | +142.2% |
| FY2013 | Dec 31, 2013 | 41M | +640.0% |
| FY2012 | Dec 31, 2012 | 6M | +5.6% |
| FY2011 | Dec 31, 2011 | 5M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 414M | +39.6% |
| Q1 FY2026 | Mar 31, 2026 | 354M | +20.6% |
| Q4 FY2025 | Dec 31, 2025 | 354M | +20.9% |
| Q3 FY2025 | Sep 30, 2025 | 307M | +11.3% |
| Q2 FY2025 | Jun 30, 2025 | 296M | +17.5% |
| Q1 FY2025 | Mar 31, 2025 | 294M | +17.9% |
| Q4 FY2024 | Dec 31, 2024 | 293M | +17.8% |
| Q3 FY2024 | Sep 30, 2024 | 276M | +11.0% |
| Q2 FY2024 | Jun 30, 2024 | 252M | +1.8% |
| Q1 FY2024 | Mar 31, 2024 | 249M | +8.5% |
| Q4 FY2023 | Dec 31, 2023 | 249M | +24.0% |
| Q3 FY2023 | Sep 30, 2023 | 249M | +23.8% |
| Q2 FY2023 | Jun 30, 2023 | 248M | +23.7% |
| Q1 FY2023 | Mar 31, 2023 | 230M | +15.1% |
| Q4 FY2022 | Dec 31, 2022 | 201M | +0.7% |
| Q3 FY2022 | Sep 30, 2022 | 201M | +0.7% |
| Q2 FY2022 | Jun 30, 2022 | 200M | +0.7% |
| Q1 FY2022 | Mar 31, 2022 | 200M | +3.2% |
| Q4 FY2021 | Dec 31, 2021 | 199M | +11.8% |
| Q3 FY2021 | Sep 30, 2021 | 199M | +20.3% |
| Q2 FY2021 | Jun 30, 2021 | 199M | +21.3% |
| Q1 FY2021 | Mar 31, 2021 | 193M | +20.7% |
| Q4 FY2020 | Dec 31, 2020 | 178M | +14.9% |
| Q3 FY2020 | Sep 30, 2020 | 166M | +7.1% |
| Q2 FY2020 | Jun 30, 2020 | 164M | +6.7% |
| Q1 FY2020 | Mar 31, 2020 | 160M | +4.8% |
| Q4 FY2019 | Dec 31, 2019 | 155M | +18.0% |
| Q3 FY2019 | Sep 30, 2019 | 155M | +19.4% |
| Q2 FY2019 | Jun 30, 2019 | 154M | +18.9% |
| Q1 FY2019 | Mar 31, 2019 | 153M | +19.8% |
| Q4 FY2018 | Dec 31, 2018 | 132M | +8.9% |
| Q3 FY2018 | Sep 30, 2018 | 130M | +7.5% |
| Q2 FY2018 | Jun 30, 2018 | 129M | +8.0% |
| Q1 FY2018 | Mar 31, 2018 | 128M | +7.3% |
| Q4 FY2017 | Dec 31, 2017 | 121M | +1.8% |
| Q3 FY2017 | Sep 30, 2017 | 121M | +1.8% |
| Q2 FY2017 | Jun 30, 2017 | 120M | – |
| Q1 FY2017 | Mar 31, 2017 | 119M | – |
| Q4 FY2016 | Dec 31, 2016 | 119M | – |
| Q3 FY2016 | Sep 30, 2016 | 118M | – |
See a number that looks wrong?